SCHEMBL7475243

SCHEMBL7475243

CN(C(=O)OC(C)(C)C)[C@@H](C=O)Cc1ccc2ccccc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSB P07858 1/20 0.46
CTSS P25774 1/20 0.46
CTSK P43235 1/20 0.46
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.41
GHSR Q92847 5/20 0.41
PTPN1 P18031 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
HTR2B P41595 1/20 0.40
MAOB P27338 1/20 0.39
PSMB5 P28074 1/20 0.39
CAPN1 P07384 1/20 0.39
MME P08473 1/20 0.39
ACE P12821 1/20 0.39
SLC1A3 P43003 1/20 0.38
SLC1A2 P43004 1/20 0.38
SLC1A1 P43005 1/20 0.38
OPRM1 P35372 1/20 0.37
TACR1 P25103 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8359762 1.00 CTSB (0.46) CTSBCTSSCTSKMMP9MMP8
SCHEMBL7473464 0.85 CTSB (0.45) CTSBCTSSCTSKMMP9MMP8
SCHEMBL7659115 0.85 ATM (0.45) CTSBCTSSCTSKACEOPRM1
SCHEMBL7893852 0.85 ATM (0.45) CTSBCTSSCTSKACEOPRM1
SCHEMBL8362266 0.83 CTSB (0.41) CTSBCTSSCTSKMMP9MMP8
SCHEMBL3266674 0.82 CTSB (0.49) CTSBCTSSCTSKMMP9MMP8
SCHEMBL29624575 0.82 CTSB (0.49) CTSBCTSSCTSKMMP9MMP8
SCHEMBL1401196 0.82 CTSB (0.49) CTSBCTSSCTSKMMP9MMP8
SCHEMBL31407327 0.82 CTSB (0.49) CTSBCTSSCTSKMMP9MMP8
SCHEMBL7286769 0.82 CTSB (0.49) CTSBCTSSCTSKMMP9MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0923550-B1 ACYLAMINOALKENYLENE-AMIDE DERIVATIVES AS NK1 AND NK2 ANTAGONISTS NOVARTIS AG (CH) 2002-09-25 EP disclosed
US-6319917-B1 NEUROGENIC INFLAMMATION AND TACHYKININ BRONCHOCONSTRICTION INHIBITORS NOVARTIS AG (CH) 2001-11-20 US disclosed
EP-0923550-A1 ACYLAMINOALKENYLENE-AMIDE DERIVATIVES AS NK1 AND NK2 ANTAGONISTS Novartis AG (CH) 1999-06-23 EP disclosed
WO-1998007694-A1 ACYLAMINOALKENYLENE-AMIDE DERIVATIVES AS NK1 AND NK2 ANTAGONISTS NOVARTIS AG (CH) 1998-02-26 WO disclosed